[Federal Register Volume 83, Number 158 (Wednesday, August 15, 2018)]
[Notices]
[Pages 40567-40568]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17605]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Rhodes 
Technologies

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before October 15, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: 
    The Attorney General has delegated his authority under the 
Controlled Substances Act to the Administrator of the Drug Enforcement 
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all 
necessary functions with respect to the promulgation and implementation 
of 21 CFR part 1301, incident to the registration of manufacturers, 
distributors, dispensers, importers, and exporters of controlled 
substances (other than final orders in connection with suspension, 
denial, or revocation of registration) has been delegated to the 
Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on June 
28th, 2018, Rhodes Technologies, 498 Washington Street, Coventry, Rhode 
Island 02816 applied to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance             Drug code         Schedule
------------------------------------------------------------------------
Marihuana...........................            7360  I
Tetrahydrocannabinols...............            7370  I
Dihydromorphine.....................            9145  I
Methylphenidate.....................            1724  II
Codeine.............................            9050  II
Dihydrocodeine......................            9120  II
Oxycodone...........................            9143  II
Hydromorphone.......................            9150  II
Hydrocodone.........................            9193  II
Levorphanol.........................            9220  II
Morphine............................            9300  II
Oripavine...........................            9330  II
Thebaine............................            9333  II
Oxymorphone.........................            9652  II
Noroxymorpohone.....................            9668  II
Tapentadol..........................            9780  II
------------------------------------------------------------------------


[[Page 40568]]

    The company plans to manufacture the listed controlled substances 
in bulk for conversion and sale to finished dosage form manufacturers. 
In reference to drug code 7360 and 7370, the company plans to bulk 
manufacture a synthetic CBD and tetrahydrocannabinol. No other activity 
for drug code 7360 and 7370 are authorized for this registration.

    Dated: August 3, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-17605 Filed 8-14-18; 8:45 am]
 BILLING CODE 4410-09-P